版权说明 操作指南
首页 > 成果 > 详情

Effect of Pirarubicin Infusion after TURBT on VEGF, FGF, MMP-s and Prognosis in Patients with Superficial Bladder Cancer

认领
导出
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Long, Jianhua;Liu, Quanqi*;Xu, Lizhen;Feng, Zhimin
通讯作者:
Liu, Quanqi
作者机构:
[Long, Jianhua] Univ South China, Affiliated Hosp 2, Dept Urol, Hengyang, Peoples R China.
[Xu, Lizhen; Liu, Quanqi] Zhejiang Univ, Jinhua Affiliated Hosp, Dept Urol, Jinhua, Zhejiang, Peoples R China.
[Feng, Zhimin] Hunan Inst Technol, Hengyang, Peoples R China.
通讯机构:
[Liu, Quanqi] Z
Zhejiang Univ, Jinhua Affiliated Hosp, Dept Urol, Jinhua, Zhejiang, Peoples R China.
语种:
英文
关键词:
TURBT;pirarubicin;Superficial bladder cancer;VEGF;FGF;MMP-s and prognosis
期刊:
Boletin de Malariologia y Salud Ambiental
ISSN:
1690-4648
年:
2019
卷:
59
期:
5
页码:
235-239
机构署名:
本校为第一机构
摘要:
This paper investigate the effect of pirarubicin infusion on vascular endothelial growth factor (VEGF), fibroblast growth factor (fibroblast growth factor), matrix metalloproteinase-s (MMP-s) and prognosis in patients with superficial bladder cancer after transurethral resection of bladder tumors (TURBT). The control group was treated with TURBT alone, and the treatment group was treated with pirarubicin after TURBT. The changes of VEGF, FGF and MMP-s levels and prognosis were compared between the two groups after treatment. The levels of vascular endothelial growth factor, alpha fibroblast gr...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com